18 results on '"Liu, Peiqing"'
Search Results
2. A Review of Toxicity Mechanism Studies of Electronic Cigarettes on Respiratory System.
- Author
-
Wang, Lilan, Wang, Yao, Chen, Jianwen, Liu, Peiqing, and Li, Min
- Subjects
- *
ELECTRONIC cigarettes , *CIGARETTES , *RESPIRATORY organs , *OXIDATIVE stress , *CELLULAR signal transduction , *INFLAMMATION - Abstract
Electronic cigarettes (e-cigarettes) have attracted much attention as a new substitute for conventional cigarettes. E-cigarettes are first exposed to the respiratory system after inhalation, and studies on the toxicity mechanisms of e-cigarettes have been reported. Current research shows that e-cigarette exposure may have potentially harmful effects on cells, animals, and humans, while the safety evaluation of the long-term effects of e-cigarette use is still unknown. Similar but not identical to conventional cigarettes, the toxicity mechanisms of e-cigarettes are mainly manifested in oxidative stress, inflammatory responses, and DNA damage. This review will summarize the toxicity mechanisms and signal pathways of conventional cigarettes and e-cigarettes concerning the respiratory system, which could give researchers a better understanding and direction on the effects of e-cigarettes on our health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Targeting KPNB1 with genkwadaphnin suppresses gastric cancer progression through the Nur77-mediated signaling pathway.
- Author
-
Zhang, Chenxi, Wang, Xiaojuan, Cai, Guodi, Wang, Hong, Liu, Qianqian, Ma, Shuai, Sun, Huizi, An, Yana, Miao, Miaomiao, Yin, Sheng, Liu, Peiqing, Wang, Xiaolu, and Wang, Junjian
- Subjects
- *
STOMACH cancer , *CANCER invasiveness , *BCL genes , *CELLULAR signal transduction , *INHIBITION of cellular proliferation , *TUMOR growth - Abstract
Gastric cancer (GC) remains a global challenge due to the lack of early detection and precision therapies. Genkwadaphnin (DD1), a natural diterpene isolated from the bud of Flos GenkWa (Thymelaeaceae), serves as a Karyopherin β1 (KPNB1) inhibitor. In this study, we investigated the anti-tumor effect of DD1 in both cell culture and animal models. Our findings reveal that KPNB1, a protein involved in nuclear import, was highly expressed in GC tissues and associated with a poor prognosis in patients. We demonstrated that DD1, alongside the established KPNB1 inhibitor importazole (IPZ), inhibited GC cell proliferation and tumor growth by enhancing both genomic and non-genomic activity of Nur77. DD1 and IPZ reduced the interaction between KPNB1 and Nur77, resulting in Nur77 cytoplasmic accumulation and triggering mitochondrial apoptosis. The inhibitors also increased the expression of the Nur77 target apoptotic genes ATF3 , RB1CC1 and PMAIP1 , inducing apoptosis in GC cell. More importantly, loss of Nur77 effectively rescued the inhibitory effect of DD1 and IPZ on GC cells in both in vitro and in vivo experiments. In this study, we for the first time explored the relationship between KPNB1 and Nur77, and found KPNB1 inhibition could significantly increase the expression of Nur77. Moreover, we investigated the function of KPNB1 in GC for the first time, and the results suggested that KPNB1 could be a potential target for cancer therapy, and DD1 might be a prospective therapeutic candidate. [Display omitted] • KPNB1 was highly expressed in gastric cancer tissues and associated with a poor patient prognosis. • KPNB1 inhibitor DD1 potently suppresses GC cell survival and tumor growth. • Nur77 acts as a key determinant of the function of KPNB1 in GC. • KPNB1 represents a potential therapeutic target in GC. • DD1 can be a promising therapeutic drug for GC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
- Author
-
Lan, Tian, Shen, Xiaoyan, Liu, Peiqing, Liu, Weihua, Xu, Suowen, Xie, Xi, Jiang, Qin, Li, Wenyuan, and Huang, Heqing
- Subjects
- *
KIDNEY injuries , *BERBERINE , *CELLULAR signal transduction , *EXTRACELLULAR matrix , *DIABETIC nephropathies , *LABORATORY mice , *IMMUNOSUPPRESSION - Abstract
Abstract: Berberine (BBR) was previously found to have beneficial effects on renal injury in experimental diabetic rats. However, the mechanisms underlying the effects are not fully understood. Sphingosine kinase–Sphingosine 1-phosphate (SphK–S1P) signaling pathway has been implicated in the pathogenesis of diabetic nephropathy (DN). The aim of this study was to investigate the effects of BBR on renal injury and the activation of SphK–S1P signaling pathway in alloxan-induced diabetic mice with nephropathy. Alloxan-induced diabetic mice were treated orally with BBR (300mg/kg/day) or vehicle for 12weeks. BBR inhibited the increases in fasting blood glucose, kidney/body weight ratio, blood urea nitrogen, serum creatinine and 24-h albuminuria in diabetic mice. It also prevented renal hypertrophy, TGF-β1 synthesis, FN and Col IV accumulation. Moreover, BBR down-regulated the elevated staining, activity and levels of mRNA and protein of SphK1, and S1P production as well. These findings suggest that the inhibitory effect of BBR on the activation of SphK–S1P signaling pathway in diabetic mouse kidney is a novel mechanism by which BBR partly exerts renoprotective effects on DN. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
5. Protein kinase CK2α catalytic subunit ameliorates diabetic renal inflammatory fibrosis via NF-κB signaling pathway.
- Author
-
Huang, Junying, Chen, Zhiquan, Li, Jie, Chen, Qiuhong, Li, Jingyan, Gong, Wenyan, Huang, Jiani, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
PROTEIN kinase C , *NF-kappa B , *FIBROSIS , *CELLULAR signal transduction , *LUCIFERASES - Abstract
Activation of casein kinase 2 (CK2) is closely linked to the body disturbance of carbohydrate metabolism and inflammatory reaction. The renal chronic inflammatory reaction in the setting of diabetes is one of the important hallmarks of diabetic renal fibrosis. However, it remains unknown whether CK2 influences the process of diabetic renal fibrosis. The current study is aimed to investigate if CK2α ameliorates renal inflammatory fibrosis in diabetes via NF-κB pathway. To explore potential regulatory mechanism of CK2α, the expression and activity of CK2α, which were studied by plasmid transfection, selective inhibitor, small-interfering RNA (siRNA) and adenovirus infection in vitro or in vivo, were analyzed by means of western blotting (WB), dual luciferase reporter assay and electrophoretic mobility shift assay (EMSA). The following findings were observed: (1) Expression of CK2α was upregulated in kidneys of db/db and KKAy diabetic mice; (2) Inhibition of CK2α kinase activity or knockdown of CK2α protein expression suppressed high glucose-induced expressions of FN and ICAM-1 in glomerular mesangial cells (GMCs); (3) Inhibition of CK2α kinase activity or knockdown of CK2α protein expression not only restrained IκB degradation, but also suppressed HG-induced nuclear accumulation, transcriptional activity and DNA binding activity of NF-κB in GMCs; (4) Treatment of TBB or CK2α RNAi adenovirus infection ameliorated renal fibrosis in diabetic animals; (5) Treatment of TBB or CK2α RNAi adenovirus infection suppressed IκB degradation and NF-κB nuclear accumulation in glomeruli of diabetic animals. This study indicates the essential role of CK2α in regulating the diabetic renal pathological process of inflammatory fibrosis via NF-κB pathway, and inhibition of CK2α may serve as a promising therapeutic strategy for diabetic nephropathy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Schisandrol B protects against cholestatic liver injury through pregnane X receptors.
- Author
-
Zeng, Hang, Jiang, Yiming, Chen, Pan, Fan, Xiaomei, Li, Dongshun, Liu, Aiming, Ma, Xiaochao, Xie, Wen, Liu, Peiqing, Gonzalez, Frank J, Huang, Min, and Bi, Huichang
- Subjects
- *
LIVER disease treatment , *URSODEOXYCHOLIC acid , *CHOLIC acid , *BILE acids , *CHOLESTASIS , *HOMEOSTASIS , *THERAPEUTICS , *LIVER injuries , *ANIMAL experimentation , *CELL receptors , *CELLULAR signal transduction , *HETEROCYCLIC compounds , *HYDROCARBONS , *LIGNANS , *LIVER , *MICE , *STEROIDS , *PREVENTION - Abstract
Background and Purpose: Currently, ursodeoxycholic acid and obeticholic acid are the only two FDA-approved drugs for cholestatic liver diseases. Thus, new therapeutic approaches need to be developed. Here we have evaluated the anti-cholestasis effects of Schisandrol B (SolB), a bioactive compound isolated from Schisandra sphenanthera.Experimental Approach: Hepatoprotective effect of SolB against intrahepatic cholestasis, induced by lithocholic acid (LCA), was evaluated in mice. Metabolomic analysis and gene analysis were used to assess involvement of pregnane X receptor (PXR). Molecular docking, cell-based reporter gene analysis and knockout mice were used to demonstrate the critical role of the PXR pathway in the anti-cholestasis effects of SolB.Key Results: SolB protected against LCA-induced intrahepatic cholestasis. Furthermore, therapeutic treatment with SolB decreased mortality in cholestatic mice. Metabolomics and gene analysis showed that SolB accelerated metabolism of bile acids, promoted bile acid efflux into the intestine, and induced hepatic expression of the PXR-target genes Cyp3a11, Ugt1a1, and Oatp2, which are involved in bile acid homeostasis. Mechanistic studies showed that SolB activated human PXR and up-regulated PXR target genes in human cell lines. Additionally, SolB did not protect Pxr-null mice from liver injury induced by intrahepatic cholestasis, thus providing genetic evidence that the effect of SolB was PXR-dependent.Conclusion and Implications: These findings provide direct evidence for the hepatoprotective effects of SolB against cholestasis by activating PXR. Therefore, SolB may provide a new and effective approach to the prevention and treatment of cholestatic liver diseases. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
7. Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway.
- Author
-
Chen, Cheng, Huang, Kaipeng, Hao, Jie, Huang, Junying, Yang, Zhiying, Xiong, Fengxiao, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
GLOMERULAR filtration rate , *KIDNEY physiology , *FIBRONECTINS , *PEOPLE with diabetes , *LABORATORY rodents , *CELLULAR signal transduction , *SPHINGOSINE kinase - Abstract
We previously demonstrated that activation of sphingosine kinase 1 (SphK1)- sphingosine 1- phosphate (S1P) signaling pathway by high glucose (HG) plays a pivotal role in increasing the expression of fibronectin (FN), an important fibrotic component, by promoting the DNA-binding activity of transcription factor activator protein 1 (AP-1) in glomerular mesangial cells (GMCs) under diabetic conditions. As a multi-target anti-oxidative drug, polydatin (PD) has been shown to have renoprotective effects on experimental diabetes. However, whether PD could resist diabetic nephropathy (DN) by regulating SphK1-S1P signaling pathway needs further investigation. Here, we found that PD significantly reversed the upregulated FN and ICAM-1 expression in GMCs exposed to AGEs. Simultaneously, PD dose-dependently inhibited SphK1 levels at the protein expression and kinase activity and attenuated S1P production under AGEs treatment conditions. In addition, PD reduced SphK activity in GMCs transfected with wild-type SphK WT plasmid and significantly suppressed SphK1-mediated increase of FN and ICAM-1 levels under normal conditions. Furthermore, we found that the AGEs-induced upregulation of phosphorylation of c-Jun at Ser63 and Ser73 and c-Fos at Ser32, DNA-binding activity and transcriptional activity of AP-1 were blocked by PD. In comparison with db/db model group, PD treatment suppressed SphK1 levels (mRNA, protein expression, and activity) and S1P production, reversed the upregulation of FN, ICAM-1, c-Jun, and c-Fos in the kidney tissues of diabetic mice, and finally ameliorated renal injury in db/db mice. These findings suggested that the downregulation of SphK1-S1P signaling pathway is probably a novel mechanism by which PD suppressed AGEs-induced FN and ICAM-1 expression and improved renal dysfunction of diabetic models. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.
- Author
-
Cao, Weiwei, Chen, Jianwen, Chen, Yanfang, Chen, Shaorui, Chen, Xi, Huang, Heqing, and Liu, Peiqing
- Subjects
- *
GLYCOSYLATION , *DENDRITIC cells , *HEART failure , *NF-kappa B , *CELLULAR signal transduction , *DIAGNOSIS - Abstract
Background and aims It is commonly believed that diabetes is an important contributor to heart failure (HF) development. However, the detail effect of diabetogenesis on HF is controversy: both beneficial and harmful roles were reported. In the present study, we aim to explore the unambiguous action of diabetes on chronic HF progression and the underlying mechanism. Methods Diabetes and myocardial infarction (MI) were induced by streptozotocin (STZ) injection and left-sided thoracotomy and left anterior descending coronary artery (LAD) ligation, respectively. Pyridoxamine was used as the antagonist of advanced glycation end products (AGEs). Adult male SD rats were assigned to 5 groups: Sham; MI; Diabetes (D); Diabetes + MI (DMI) and DMI + pyridoxamine (DMI + P). Animals were sacrificed at the end of 12 weeks. The comparison of LV myocardium was made between border zone from MI or DMI animals and control LV tissues from sham-operated animals. Cardiomyocytes and dendritic cells were prepared from the Sprague–Dawley rats and cocultured in the presence or absence of AGEs. Results DMI group showed highest level of AGEs and inflammatory markers, which were significantly reduced in the presence of pyridoxamine. In vitro experiment disclosed AGEs could stimulate DCs differentiation and promote cytokines production, finally upregulated hypertrophy-related genes expression in cardiocytes. Intervention DCs differentiation was sufficient to improve cardiocytes morphology. Conclusion Our results clearly demonstrate that diabetes would promote chronic HF progression at least in part through stimulating DCs differentiation and series downstream inflammatory responses induced by AGEs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. AMDE-1 Is a Dual Function Chemical for Autophagy Activation and Inhibition.
- Author
-
Li, Min, Yang, Zuolong, Vollmer, Laura L., Gao, Ying, Fu, Yuanyuan, Liu, Cui, Chen, Xiaoyun, Liu, Peiqing, Vogt, Andreas, and Yin, Xiao-Ming
- Subjects
- *
AUTOPHAGY , *ENZYME inhibitors , *ENZYME activation , *HOMEOSTASIS , *GREEN fluorescent protein , *MITOGEN-activated protein kinases , *CELLULAR signal transduction - Abstract
Autophagy is the process by which cytosolic components and organelles are delivered to the lysosome for degradation. Autophagy plays important roles in cellular homeostasis and disease pathogenesis. Small chemical molecules that can modulate autophagy activity may have pharmacological value for treating diseases. Using a GFP-LC3-based high content screening assay we identified a novel chemical that is able to modulate autophagy at both initiation and degradation levels. This molecule, termed as utophagy odulator with ual ffect-1 (AMDE-1), triggered autophagy in an Atg5-dependent manner, recruiting Atg16 to the pre-autophagosomal site and causing LC3 lipidation. AMDE-1 induced autophagy through the activation of AMPK, which inactivated mTORC1 and activated ULK1. AMDE-1did not affect MAP kinase, JNK or oxidative stress signaling for autophagy induction. Surprisingly, treatment with AMDE-1 resulted in impairment in autophagic flux and inhibition of long-lived protein degradation. This inhibition was correlated with a reduction in lysosomal degradation capacity but not with autophagosome-lysosome fusion. Further analysis indicated that AMDE-1 caused a reduction in lysosome acidity and lysosomal proteolytic activity, suggesting that it suppressed general lysosome function. AMDE-1 thus also impaired endocytosis-mediated EGF receptor degradation. The dual effects of AMDE-1 on autophagy induction and lysosomal degradation suggested that its net effect would likely lead to autophagic stress and lysosome dysfunction, and therefore cell death. Indeed, AMDE-1 triggered necroptosis and was preferentially cytotoxic to cancer cells. In conclusion, this study identified a new class of autophagy modulators with dual effects, which can be explored for potential uses in cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
- Author
-
Huang, Qiuju, Huang, Jinxian, Zeng, Zhenhua, Luo, Jiani, Liu, Peiqing, Chen, Shaorui, Liu, Bing, Pan, Xuediao, Zang, Linquan, and Zhou, Sigui
- Subjects
- *
HEART cells , *HYPERTROPHY , *SOMATOMEDIN , *CELLULAR signal transduction , *PHENYLEPHRINE , *CELL physiology , *ACYL-CoA dehydrogenases - Abstract
Aims Short-chain acyl-CoA dehydrogenase (SCAD) is a key enzyme in fatty acid oxidation. In the present study we aim to investigate the changes in SCAD between pathological and physiological cardiomyocyte hypertrophy. We also explore the different signaling pathways of pathological and physiological cardiomyocyte hypertrophy. Main methods After neonatal rat cardiomyocytes were treated as setups, cell surface area, expression of SCAD, PPARα, phospho-ERK1/2, activity of SCAD, free fatty acid content and ATP content in the cardiomyocytes were measured. Key findings Neonatal rat cardiomyocytes treated by PE showed an increased cell surface area and free fatty acid content, increased ERK1/2 phosphorylation, decreased expression of PPARα, decreased expression and activity of SCAD and decreased levels of ATP. Neonatal rat cardiomyocytes treated by IGF-1 showed the reverse effects except for the cell surface area. PPARα inhibitor GW6471 and PPARα activator Fenofibrate treatments abrogated the effects induced by IGF-1 and PE in cardiomyocytes respectively, as well as ERK1/2 activator EGF and ERK1/2 inhibitor PD98059. Significance SCAD has different changes between pathological and physiological cardiomyocyte hypertrophy. The ERK1/2/PPARα/SCAD signaling pathways play different roles in pathological and physiological cardiomyocyte hypertrophy. SCAD may be used as a new target to prevent the development of pathological cardiac hypertrophy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
- Author
-
Hao, Jie, Chen, Cheng, Huang, Kaipeng, Huang, Junying, Li, Jie, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
GLUCOSE metabolism , *LIPID metabolism , *STILBENE , *TREATMENT of diabetes , *PROTEIN kinase B , *CELLULAR signal transduction - Abstract
Recently, the effect of polydatin on lipid regulation has gained considerable attention. And previous study has demonstrated that polydatin has hypoglycemic effect on experimental diabetic rats. Repressed Akt pathway contributes to glucose and lipid disorders in diabetes. Thus, whether polydatin regulates glucose and lipid metabolism in experimental diabetic models through the Akt pathway arouses interest. The purpose was to explore the regulatory mechanism of polydain on glucose and lipid through Akt pathway. We used a diabetic rat model induced by high-fat and -sugar diet with low-dose of streptozocin and an insulin resistant HepG2 cell model induced by palmitic acid to clarify the role of polydatin on glucose and lipid metabolism. Here, we found that polydatin significantly attenuated fasting blood–glucose, glycosylated hemoglobin, glycosylated serum protein, total cholesterol, triglyceride, and low-density lipoprotein cholesterol in diabetic rats. Furthermore, polydatin significantly increased glucose uptake and consumption and decreased lipid accumulation in insulin resistant HepG2 cells. Polydatin markedly increased serum insulin levels in diabetic rats, and obviously activated the Akt signaling pathway in diabetic rat livers and insulin resistant HepG2 cells. Polydatin markedly increased phosphorylated GSK-3β, decreased the protein levels of G6Pase and SREBP-1c, and increased protein levels of GCK, LDLR, and phosphorylated IRS in livers and HepG2 cells. Overall, the results indicate that polydatin regulates glucose and lipid metabolism in experimental diabetic models, the underlying mechanism is probably associated with regulating the Akt pathway. The effect of polydatin on increased Akt phosphorylation is independent of prompting insulin secretion, but dependent of increasing IRS phosphorylation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
- Author
-
Xie, Xi, Chang, Xiuting, Chen, Lei, Huang, Kaipeng, Huang, Juan, Wang, Shaogui, Shen, Xiaoyan, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
BERBERINE , *DIABETES , *KIDNEY diseases , *INFLAMMATION , *FIBRONECTINS , *RHO GTPases , *CELLULAR signal transduction , *EXTRACELLULAR matrix proteins , *PHYSIOLOGY - Abstract
Highlights: [•] We confirm the importance of berberine in ECM protein accumulation in DN. [•] We examine the regulation of RhoA/ROCK signaling by berberine in DN. [•] Berberine regulates NF-κB in DN. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
13. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy
- Author
-
Xie, Xi, Peng, Jing, Chang, Xiuting, Huang, Kaipeng, Huang, Juan, Wang, Shaogui, Shen, Xiaoyan, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
NF-kappa B , *CELLULAR signal transduction , *DIABETIC nephropathies , *CELL culture , *CHROMOSOMAL translocation , *EXTRACELLULAR matrix , *HEMAGGLUTININ - Abstract
Abstract: Both RhoA/ROCK and NF-κB signaling pathways play important roles in the pathogenesis of diabetic nephropathy (DN). However, it remains unknown whether and how RhoA/ROCK regulates NF-κB signaling in diabetic kidneys. In cultured glomerular mesangial cells (GMCs), the high glucose-activated NF-κB nuclear translocation and DNA binding activity were attenuated by ROCK inhibitor Y27632 or dominant-negative RhoA mutant, indicating that RhoA/ROCK signaling regulates high glucose-activated NF-κB pathway. Furthermore, NF-κB-regulated inflammatory factors ICAM-1 and TGF-β1 were markedly increased in high glucose-treated GMCs, leading to accumulation of fibronectin (FN), an important component of extracellular matrix (ECM), This effect was also effectively attenuated by Y27632 or dominant-negative RhoA mutant. In STZ-induced diabetic rats, treatment with ROCK inhibitor fasudil suppressed the RhoA/ROCK activation and NF-κB nuclear translocation, and significantly reduced the renal FN, ICAM-1 and TGF-β1 protein levels. Thus, the RhoA/ROCK pathway may regulate NF-κB to upregulate inflammatory genes and mediate the development of DN. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
14. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway
- Author
-
Huang, Juan, Huang, Kaipeng, Lan, Tian, Xie, Xi, Shen, Xiaoyan, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
CURCUMIN , *DIABETIC nephropathies , *POLYPHENOLS , *RENAL fibrosis , *GROWTH factors , *GLOMERULAR filtration rate , *SPHINGOSINE-1-phosphate , *CELLULAR signal transduction - Abstract
Abstract: Curcumin, a major polyphenol from the golden spice Curcuma longa commonly known as turmeric, has been recently discovered to have renoprotective effects on diabetic nephropathy (DN). However, the mechanisms underlying these effects remain unclear. We previously demonstrated that the sphingosine kinase 1-sphingosine 1-phosphate (SphK1-S1P) signaling pathway plays a pivotal role in the pathogenesis of DN. This study aims to investigate whether the renoprotective effects of curcumin on DN are associated with its inhibitory effects on the SphK1-S1P signaling pathway. Our results demonstrated that the expression and activity of SphK1 and the production of S1P were significantly down-regulated by curcumin in diabetic rat kidneys and glomerular mesangial cells (GMCs) exposed to high glucose (HG). Simultaneously, SphK1-S1P-mediated fibronectin (FN) and transforming growth factor-beta 1 (TGF-β1) overproduction were inhibited. In addition, curcumin dose dependently reduced SphK1 expression and activity in GMCs transfected with SphKWT and significantly suppressed the increase in SphK1-mediated FN levels. Furthermore, curcumin inhibited the DNA-binding activity of activator protein 1 (AP-1), and c-Jun small interference RNA (c-Jun-siRNA) reversed the HG-induced up-regulation of SphK1. These findings suggested that down-regulation of the SphK1-S1P pathway is probably a novel mechanism by which curcumin improves the progression of DN. Inhibiting AP-1 activation is one of the therapeutic targets of curcumin to modulate the SphK1-S1P signaling pathway, thereby preventing diabetic renal fibrosis. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
15. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells
- Author
-
Xie, Xi, Peng, Jing, Huang, Kaipeng, Huang, Juan, Shen, Xiaoyan, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
FIBRONECTINS , *NF-kappa B , *CELLULAR signal transduction , *DIABETIC nephropathies , *EXTRACELLULAR matrix , *LABORATORY rats , *TRANSFORMING growth factors-beta , *CELL adhesion molecules , *STREPTOZOTOCIN - Abstract
Abstract: A number of studies have recently demonstrated the involvement of nuclear factor-kappa B (NF-κB) activation and the subsequent coordinated inflammatory responses in the pathogenesis of diabetic nephropathy (DN). Polydatin has been shown to have the ability of anti-adhesive inflammation. However, the possible protective and beneficial effects of polydatin on DN via suppressing inflammatory damage and extracellular matrix (ECM) accumulation are not fully elucidated. We found that the polydatin could inhibit the induction and activity of NF-κB, and meanwhile ameliorating ECM accumulation in streptozotocin-diabetic rats. We aimed to investigate the effect of polydatin on fibronectin (FN) protein expression, and to elucidate its potential mechanism involving the NF-κB inflammatory signaling pathway in rat glomerular mesangial cells (GMCs) cultured under high glucose. The results revealed that polydatin significantly suppressed high glucose-induced FN production, inhibited NF-κB nuclear translocation, reduced the DNA-binding activity of NF-κB, as well as decreased the protein expression of ICAM-1 and TGF-β in GMCs. These findings suggested that polydatin significantly represses high glucose-induced FN expression in rat GMCs, which may be closely related to its inhibition of the NF-κB signaling pathway. Hence, we elucidated the potential mechanisms of the anti-inflammatory effects and ECM accumulation alleviation of polydatin in GMCs of DN in vitro. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
16. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition
- Author
-
Liu, Weihua, Lan, Tian, Xie, Xi, Huang, Kaipeng, Peng, Jing, Huang, Juan, Shen, Xiaoyan, Liu, Peiqing, and Huang, Heqing
- Subjects
- *
SPHINGOSINE-1-phosphate , *FIBRONECTINS , *GLUCOSE , *EXTRACELLULAR matrix , *DIABETIC nephropathies , *LABORATORY rats , *MITOGEN-activated protein kinases , *CELLULAR signal transduction - Abstract
Abstract: Accumulation of extracellular matrix including fibronectin in mesangium is one of the major pathologic characteristics in diabetic nephropathy. In the current study, we explored role of sphingosine-1-phosphate (S1P) receptor in fibronectin expression and underlying molecular mechanism. Among five S1P receptors the mRNA level of S1P2 receptor was the most abundant in kidney of diabetic rats and mesangial cells under high glucose condition. S1P augmentation of fibronectin was significantly inhibited by S1P2 receptor antagonist JTE-013 and S1P2-siRNA. S1P-stimulated fibronectin expression was remarkably blocked by ERK1/2 inhibitor PD98059 and p38MAPK inhibitor SB203580. Phospho-ERK1/2 and phospho-p38MAPK level induced by S1P were markedly abrogated by JTE-013 and S1P2-siRNA. In conclusion, S1P2 receptor was significantly up-regulated under diabetic condition. S1P2 receptor mediated fibronectin expression through the activation of S1P-S1P2-MAPK (ERK1/2 and p38MAPK) axis in mesangial cells under high glucose condition, suggesting that it might be a potential therapeutic target for diabetic nephropathy treatment. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
17. Cryptotanshinione upregulates α-secretase by activation PI3K pathway in cortical neurons
- Author
-
Mei, Zhengrong, Situ, Bing, Tan, Xiangping, Zheng, Shiming, Zhang, Fangyan, Yan, Pengke, and Liu, Peiqing
- Subjects
- *
AMYLOID beta-protein precursor , *CELLULAR signal transduction , *NEURONS , *CEREBRAL cortex , *HERBAL medicine , *METALLOPROTEINASES - Abstract
Abstract: The amyloid precursor protein (APP) is cleaved enzymatically by nonamyloidogenic and amyloidogenic pathways. α-Secretase cleaves APP within β amyloid protein (Aβ) sequence, resulting in the release of a secreted fragment of APP (sAPPα) and precluding Aβ generation. Cryptotanshinone (CTS), an active component of the medicinal herb Salvia miltiorrhiza, has been shown to improve learning and memory in several pharmacological models of Alzheimer''s disease (AD). We have shown previously that CTS modulated APP metabolism by elevation α-secretase activity. However, the molecular mechanisms involved were unclear. Here we reported that CTS increased α-secretase activity and sAPPα release. To gain insight into the molecular mechanism whereby CTS modulates α-secretase, we evaluated the involvement of three candidate α-secretase enzymes, a-disintegrin and metalloprotease (ADAM) 9, 10, or 17, in CTS-induced non-amyloidogenic APP metabolism. Results showed that CTS treatment of cortical neurons overexpressing Swedish mutant human APP695 markedly elevated ADAM10 protein, and the inhibitor of ADAM10 inhibited the CTS-induced increase in α-secretase activity, suggesting CTS modulated α-secretase activity by upregulation ADAM10 protein. By using several specific protein kinase inhibitors, we showed that phosphatidylinositol 3-kinase (PI3K) mediated the CTS-induced α-secretase activation. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
18. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose
- Author
-
Li, Xuejuan, Liu, Weihua, Wang, Qin, Liu, Peiqing, Deng, Yanhui, Lan, Tian, Zhang, Xiaoyan, Qiu, Baoming, Ning, Hairong, and Huang, Heqing
- Subjects
- *
CELL proliferation -- Molecular aspects , *ANTHRAQUINONES , *FIBRONECTINS , *GENE expression , *CELLULAR signal transduction , *LABORATORY rats , *CELL culture , *CELL cycle regulation - Abstract
Abstract: Our previous findings demonstrated that emodin could improve the renal function in rats with diabetic nephropathy, but little is known about its molecular mechanisms. In this study, we investigated the effects of emodin on high glucose (HG)-induced cell proliferation and fibronectin (FN) protein expression in rat mesangial cells, and explored the possible mechanism. Cell proliferation and cell cycle were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry assay, respectively. The protein levels of FN, p-p38MAPK, t-p38MAPK, p-CREB, PPARγ, and CTGF in rat mesangial cells were detected by Western blot. Our results demonstrated that emodin significantly suppressed HG-induced cell proliferation and arrested cell cycle progress. Protein expression of FN, phospho-p38MAPK, phospho-CREB and CTGF was markedly reduced, and PPARγ protein level was significantly increased after emodin treatment. In conclusion, emodin suppressed HG-induced cell proliferation and FN expression in rat mesangial cells through inhibiting the p38MAPK pathway involved CREB, PPAPγ and CTGF, suggesting a potential role of emodin in the treatment of diabetic nephropathy. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.